20 Dec Federal Rescheduling Is a Big Step — But the Fight for Real Reform Continues
The landscape of federal cannabis policy just shifted in a historic way, and it affects all of us in the cannabis community — patients, growers, advocates, and everyday users. On December 18, 2025, President Donald Trump signed an executive order directing federal agencies to reschedule marijuana from a Schedule I drug to Schedule III under the Controlled Substances Act — the most significant federal cannabis action in decades.
But before you celebrate or panic, it’s important to understand what this truly means — and why this isn’t the end of the reform movement.
What Rescheduling Actually Does
For nearly 55 years, cannabis has been federally classified alongside heroin and LSD — as a Schedule I substance with “no accepted medical use” and a high potential for misuse.
With the new executive order:
- Cannabis is being repositioned in federal law to Schedule III, acknowledging medical uses and lower risk than other controlled substances.
- The administration is also expanding access to regulated plant-derived CBD and exploring pathways for Medicare reimbursement for CBD therapies.
- This could easier medical research, recognize medical cannabis use nationally, and provide policy relief for patients and veterans.
These are meaningful milestones, especially given how research and medical access have been hindered by decades of prohibition.
But It’s Not Federal Legalization
This is where things get nuanced.
Even with rescheduling:
- Cannabis remains illegal at the federal level for most purposes.
- Federal criminal penalties still exist for unapproved possession, distribution, and sales.
- Banking access and tax barriers for state-legal businesses remain unresolved unless Congress acts.
- Past convictions aren’t automatically cleared, leaving individuals impacted by old laws without relief.
Rescheduling improves the baseline, but it doesn’t harmonize federal law with what nearly half the states already do — or guarantee common-sense reforms like banking protections, expungement, and interstate commerce rights.
This means that the state–federal clash over cannabis policy is still very much alive.
Why the Fight Isn’t Over
Advocates agree that this executive order is a step forward — but it still leaves many goals unmet. Leaders in the reform community are clear:
- This change legitimizes the medical value of cannabis under federal law.
- It helps dispel decades-old myths about cannabis harm.
- But it doesn’t fully fix the conflict between federal and state cannabis laws.
The real victory will come when comprehensive federal legislation removes cannabis from the Controlled Substances Act entirely — bringing federal law into alignment with science, public opinion, and the realities on the ground.
Stay Informed, Stay Engaged
At Chillum, we believe in empowering our community with not just good products, but also good policy education. This moment in federal cannabis history is important — but it’s just one chapter, not the whole story.
No Comments